Vertex Pharmaceuticals’ cystic fibrosis (CF) therapy Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) has been approved by the European Commission (EC).

Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...

A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of ...

“ [These] strong phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in ...

The European Commission (EC) has granted conditional approval to Jazz Pharmaceuticals’ Ziihera (zanidatamab) to treat a ...

Camera fatigue: being on camera means always being on show. This can be distracting for some individuals who are constantly ...

Implementing AI in regulated industries like healthcare requires more than advanced technology. It demands strategic ...

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Bertolini has been with The Considered since its beginnings in 2021, first as senior operations manager, then vice president ...

Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...

The Communiqué Awards returned for its 27th year on 3 July to celebrate excellence in healthcare communications and showcase ...

The UK government has published its 10 Year Health Plan for England, which will see millions of patients be treated and cared ...